Praxis Precision Medicines (PRAX) Profit After Tax (QoQ) (2019 - 2026)

Praxis Precision Medicines (PRAX) Profit After Tax (QoQ) (2019 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn -
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn -
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn
7 Belite Bio 62.72 Bn 62.72 Bn -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn -
10 Praxis Precision Medicines 9.20 Bn 8.42 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.11%
Dec 31, 2025 -20.30%
Sep 30, 2025 -3.95%
Jun 30, 2025 -2.64%
Mar 31, 2025 -18.09%
Dec 31, 2024 -13.04%
Sep 30, 2024 -58.86%
Jun 30, 2024 17.38%
Mar 31, 2024 -47.16%
Dec 31, 2023 -9.12%
Sep 30, 2023 28.21%
Jun 30, 2023 8.39%
Mar 31, 2023 9.03%
Dec 31, 2022 6.31%
Sep 30, 2022 26.99%
Jun 30, 2022 12.40%
Mar 31, 2022 -17.30%
Dec 31, 2021 -31.04%
Sep 30, 2021 -22.81%
Jun 30, 2021 -32.98%